S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The only accurate crypto trading system I know … (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:BXRX

Baudax Bio (BXRX) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)
Free BXRX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.02
▼
$0.02
50-Day Range
$0.02
▼
$0.03
52-Week Range
$0.01
▼
$3.47
Volume
310,800 shs
Average Volume
281,029 shs
Market Capitalization
$1.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media
BXRX stock logo

About Baudax Bio Stock (NASDAQ:BXRX)

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.

BXRX Stock News Headlines

April 8, 2024 | americanbankingnews.com
Baudax Bio (NASDAQ:BXRX) versus Travere Therapeutics (NASDAQ:TVTX) Head-To-Head Review
October 18, 2023 | finance.yahoo.com
Baudax Bio Announces Corporate Update
April 18, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
October 2, 2023 | msn.com
Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag
September 28, 2023 | investorplace.com
Why Is Baudax Bio (BXRX) Stock Up 75% Today?
September 28, 2023 | marketwatch.com
Baudax Bio Shares Double After Orphan Drug Designation for TI-168
September 28, 2023 | markets.businessinsider.com
Baudax Bio: FDA Grants Orphan Drug Designation To TI-168 For Hemophilia A With Inhibitors
September 18, 2023 | finance.yahoo.com
Here's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock Now
April 18, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
September 7, 2023 | finance.yahoo.com
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
August 23, 2023 | finance.yahoo.com
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
August 17, 2023 | finance.yahoo.com
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
August 16, 2023 | finance.yahoo.com
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
June 30, 2023 | investorplace.com
Why Is Baudax Bio (BXRX) Stock Up 130% Today?
June 8, 2023 | markets.businessinsider.com
Baudax Bio (BXRX) Gets a Hold from Noble Financial
May 22, 2023 | markets.businessinsider.com
Noble Financial Sticks to Their Hold Rating for Baudax Bio (BXRX)
May 15, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Cocrystal Pharma (COCP) and Baudax Bio (BXRX)
May 12, 2023 | finanznachrichten.de
Baudax Bio, Inc.: Baudax Bio Reports First Quarter Financial Results and Provides Business Update
May 12, 2023 | baystreet.ca
Baudax Improves on Q1 Results
May 12, 2023 | msn.com
Recap: Baudax Bio Q1 Earnings
May 12, 2023 | finance.yahoo.com
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
May 3, 2023 | finance.yahoo.com
Baudax Bio to Present at the Sidoti Virtual Investor Conference
May 1, 2023 | finance.yahoo.com
Baudax Bio Announces Closing of $4 Million Public Offering
April 27, 2023 | msn.com
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 27, 2023 | investorplace.com
Why Is Baudax Bio (BXRX) Stock Down 52% Today?
April 27, 2023 | finance.yahoo.com
Baudax Bio Announces Pricing of $4 Million Public Offering
April 25, 2023 | msn.com
Baudax Bio Soars after Positive Topline Data
See More Headlines
Receive BXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/16/2023
Today
4/18/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BXRX
CUSIP
N/A
CIK
1780097
Web
www.baudaxbio.com
Phone
484-395-2440
Fax
484-395-2471
Employees
9
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($9.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-58,790,000.00
Net Margins
N/A
Pretax Margin
-18,950.64%
Return on Equity
N/A
Return on Assets
-175.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
$1.27 million
Price / Sales
0.90
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($14.93) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
52,460,000
Free Float
52,408,000
Market Cap
$1.14 million
Optionable
Not Optionable
Beta
1.57
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Geraldine A. Henwood Ph.D. (Age 72)
    President, CEO & Director
    Comp: $633.25k
  • Mike Choi
    Vice President of Financial Planning & Analysis
  • Ms. Natalie McAndrew (Age 53)
    Consultant & Principle Accounting Officer
  • Dr. Chan Kim Yong Ph.D. (Age 50)
    Chief Scientific Officer & Director

Key Competitors

View All Competitors

BXRX Stock Analysis - Frequently Asked Questions

When is Baudax Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our BXRX earnings forecast.

How were Baudax Bio's earnings last quarter?

Baudax Bio, Inc. (NASDAQ:BXRX) issued its earnings results on Wednesday, August, 16th. The company reported ($1.49) EPS for the quarter, beating analysts' consensus estimates of ($2.04) by $0.55.

When did Baudax Bio's stock split?

Baudax Bio shares reverse split on the morning of Wednesday, November 30th 2022. The 1-40 reverse split was announced on Wednesday, November 30th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Baudax Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baudax Bio investors own include Sorrento Therapeutics (SRNE), Coty (COTY), NIO (NIO), VBI Vaccines (VBIV), ADMA Biologics (ADMA), Energy Transfer (ET), Remark (MARK), Designer Brands (DBI), Geron (GERN) and Matinas BioPharma (MTNB).

This page (NASDAQ:BXRX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends